Voyager Therapeutics Inc (VYGR) — Long-term Investment Intensity
Voyager Therapeutics Inc (VYGR) has a Long-term Investment Intensity of 16.7% as of March 2025. Long-term investments of $59.10 Million represent 16.7% of total assets of $353.24 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check VYGR capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Voyager Therapeutics Inc Long-term Investment Intensity (2014–2024)
This chart shows how Voyager Therapeutics Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2014 to 2024. As of March 2025, the intensity stands at 16.7%, reflecting long-term investments of $59.10 Million against total assets of $353.24 Million USD. Explore cash flow to debt ratio of Voyager Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Voyager Therapeutics Inc (2014–2024)
The table below presents the year-by-year Long-term Investment Intensity for Voyager Therapeutics Inc from 2014 to 2024, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Voyager Therapeutics Inc market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 16.7% | $65.70 Million | $393.05 Million | ▲ +16.2 pp |
| 2019 | 0.5% | $1.92 Million | $354.76 Million | ▲ +0.2 pp |
| 2018 | 0.4% | $628.00K | $177.03 Million | ▼ -0.2 pp |
| 2017 | 0.6% | $1.10 Million | $184.48 Million | ▼ -0.1 pp |
| 2016 | 0.7% | $1.36 Million | $189.57 Million | ▼ -12.4 pp |
| 2015 | 13.1% | $30.01 Million | $229.46 Million | ▼ -247.9 pp |
| 2014 | 261.0% | $30.01 Million | $11.50 Million | — |